Mulat Ayele | Clinical | Best Researcher Award

Posted on by ScienceFather

Mr. Mulat Ayele | Clinical | Best Researcher Award

Lecturer at Department of Midwifery, College of Health Science, Woldia University, Ethiopia

Summary:

Mr. Mulat Ayele is a distinguished clinical midwife and researcher with a Master of Science in Clinical Midwifery from the University of Gondar, Ethiopia, where he graduated in 2022 as the top scorer. He also holds a Bachelor of Science in Midwifery from Woldia University, where he excelled academically. Mr. Ayele has a strong research background, with multiple publications in reputable, peer-reviewed journals, focusing on obstetrics and gynecology. Currently, he serves as a lecturer and clinician at Woldia University, where he is actively involved in teaching, clinical practice, and research. His expertise lies in maternal and perinatal outcomes associated with obstetric interventions, particularly in low- and middle-income countries.

Profile:

Education:

Mr. Mulat Ayele holds a Master of Science in Clinical Midwifery from the University of Gondar, Ethiopia, where he graduated in July 2022 with an outstanding GPA of 3.97/4.0, making him the top scorer in his cohort. His thesis, titled “Caesarean Delivery and Associated Factors Among Women Who Give Birth in North-West Amhara Referral Hospitals by Using Robson’s Group Ten Classification,” received an excellent grade, reflecting his deep expertise in the field. Prior to this, he earned a Bachelor of Science in Midwifery from Woldia University, Ethiopia, in July 2017, also graduating as the top scorer in his department with a GPA of 3.94/4.0. His research project on “Knowledge on Obstetric Danger Signs of Pregnancy and Associated Factors Among Pregnant Women Who Attend ANC in Alamata General Hospital, Southern Tigray, Ethiopia” was highly commended, further demonstrating his academic excellence and commitment to advancing maternal and child health.

Professional Experience:

Mr. Mulat Ayele has accumulated extensive professional experience in both academic and clinical settings. He is currently serving as a Lecturer and Clinician at Woldia University since July 2022, where he teaches, supervises clinical practice in hospitals, conducts research, and engages in community service. Prior to this, he worked as an Assistant Lecturer at Woldia University from July 2018 to July 2019 and as a Graduate Assistant from July 2017 to July 2018. During his tenure, Mr. Ayele has been actively involved in various departmental roles and committees, consistently receiving high job evaluation scores. His professional journey is marked by his commitment to advancing maternal and perinatal health, particularly in the context of obstetric interventions in low- and middle-income countries.

Research Interests:

Mr. Mulat Ayele’s research interests are deeply rooted in the field of maternal and perinatal health, with a specific focus on the impact of obstetric interventions in low- and middle-income countries. As a clinical midwife, he is particularly interested in exploring the multifaceted factors associated with the increased uptake of caesarean deliveries and other obstetric interventions, as well as their short- and long-term outcomes for both mothers and newborns. Mr. Ayele is also passionate about qualitative research, which allows him to examine the experiences and perceptions of healthcare providers and the communities they serve. His dedication to improving maternal and perinatal outcomes drives his commitment to research that can make a significant difference in healthcare practices and policies in resource-limited settings.

Conclution:

Mr. Mulat Ayele’s academic background, research achievements, and professional experience make him a highly suitable candidate for the “Research for Best Researcher Award.” His work in maternal and perinatal health, particularly in the context of low- and middle-income countries, is not only relevant but also impactful, positioning him as a deserving recipient of such recognition.

Publication Top Noted:

  • Nonpneumatic anti-shock garment utilization for obstetric hemorrhage management and its predictors among obstetric care providers in Ethiopia: a systematic review and meta-analysis
    • Journal: BMC Health Services Research
    • Year: 2024
    • Volume: 24(1), Article: 874
    • Authors: Lake, E.S., Ayele, M., Yilak, G., Zemariam, A.B., Kumie, G.
  • Magnitude and associated factors of unmet need for family planning among reproductive-aged women in Ethiopia: An umbrella review
    • Journal: PLoS ONE
    • Year: 2024
    • Volume: 19(8 August), Article: e0308085
    • Authors: Ayele, M., Yilak, G., Alamrew, A., Lake, E.S., Tilahun, B.D.
  • Prevalence of ineffective breastfeeding techniques and its associated factors among breastfeeding mothers in Ethiopia: A systematic review and meta-analysis
    • Journal: PLoS ONE
    • Year: 2024
    • Volume: 19(6 June), Article: e0303749
    • Authors: Yilak, G., Tilahun, B.D., Abate, B.B., Ayele, M., Belay, A.S.
  • Analysis of caesarean delivery rates using Robson ten group classification system in North West Amhara referral hospitals, Ethiopia, 2022: A cross-sectional study
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24, Article: e02237
    • Authors: Ayele, M., Berta, M., Zewdie, A., Lake, E.S., Belayneh, M.
  • Surgical site infection following cesarean section and its predictors in Ethiopia: A systematic review and meta-analysis
    • Journal: PLoS ONE
    • Year: 2024
    • Volume: 19(3 March), Article: e0296767
    • Authors: Lake, E.S., Alamrew, A., Belay, W.S., Abita, Z., Ayele, M.
  • Exploring the perceptions of health service providers and adolescents on the utilization of adolescent sexual and reproductive health services in Tikur, 2023: A qualitative study
    • Journal: SAGE Open Medicine
    • Year: 2024
    • Volume: 12
    • Authors: Tilahun, B.D., Yilak, G., Amena, S., Abebe, G.K., Ayele, M.
  • Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis
    • Journal: BMC Public Health
    • Year: 2023
    • Volume: 23(1), Article: 1369
    • Authors: Zewdie, A., Kasahun, A.W., Habtie, A., Gashaw, A., Ayele, M.
  • Determinants of evidence-based practice among health care professionals in Ethiopia: A systematic review and meta-analysis
    • Journal: PLoS ONE
    • Year: 2023
    • Volume: 18(11 November), Article: e0293902
    • Authors: Zewdie, A., Ayele, M., Melis, T., Kasahun, A.W.

Xichun Hu | Medicine | Best Researcher Award

Posted on by ScienceFather

Prof. Xichun Hu | Medicine | Best Researcher Award

Professor at Fudan University Shanghai Cancer Center, China

Summary:

Prof. Xichun Hu is a renowned oncologist specializing in oncology treatment. He was born on December 14, 1965, in Yancheng, Jiangsu Province, China. Prof. Hu earned his Bachelor of Medicine from Suzhou Medical College in 1988, followed by a Master of Oncology from Shanghai Medical University in 1991. He completed his Doctorate at The University of Hong Kong in 2001. His academic journey includes advanced training in hospital management and clinical trials from prestigious institutions like the Vienna School of Clinical Research and Mayo Clinic.

 

Profile:

Education:

Prof. Xichun Hu’s educational background is distinguished and extensive. He completed his Bachelor of Medicine at Suzhou Medical College from September 1983 to July 1988. He pursued further specialization in oncology by obtaining a Master of Oncology from Shanghai Medical University Graduate School between September 1988 and July 1991. Prof. Hu then advanced his expertise with a Doctorate from The University of Hong Kong, where he studied from April 1998 to November 2001. His commitment to continuous learning is evident from his participation in advanced training programs, including the Hospital Management Advanced Training Program for Middle-level Cadres at Cancer Otolaryngology Hospital in 2006, and Clinical Trials in Oncology at Vienna School of Clinical Research, Shanghai in 2006. Additionally, he underwent Clinical Trials Training at Mayo Clinic, USA, in 2007, where he was awarded the ICRE fellow by the National Foundation for Cancer Research, further showcasing his dedication to advancing his knowledge and skills in the field of oncology.

Professional Experience:

Prof. Xichun Hu’s extensive professional career in oncology spans several decades. He began as a Resident Physician at Shanghai Medical University Cancer Hospital from July 1988 to June 1994, where he honed his clinical skills. He was promoted to Attending Physician at the same institution from June 1994 to March 1998. His career progressed as he took on the role of Attending Physician at Fudan University Cancer Hospital from December 2001 to November 2002. Prof. Hu was subsequently appointed Associate Chief Physician at Fudan University Cancer Hospital, serving from November 2002 to April 2008. He also held the position of Executive Vice President at the hospital’s Minhang Branch from December 2006 to March 2008. Since April 2008, Prof. Hu has been a Chief Physician and Professor at Fudan University Cancer Hospital, where he continues to lead and innovate in oncology treatment. His roles have included Doctoral Supervisor (2012–present), Deputy Director of the Chemotherapy Department (February 2006 – December 2014), Acting Deputy Director of the Oncology Department (December 2014 – March 2016), and Executive Deputy Director of the Clinical Trial Institution (March 2016 – present). He has been the Director of the Oncology Department since June 2016, shaping the future of cancer care through his leadership and expertise.

Research Interests:

Prof. Xichun Hu’s research interests are deeply rooted in oncology, with a focus on advancing the treatment and understanding of breast cancer. His work explores various dimensions of cancer biology and therapy, including hormone receptor-positive and HER2-negative advanced breast cancer, and the heterogeneity between primary and metastatic cancer. Prof. Hu investigates the efficacy of novel treatments such as Pyrotinib plus capecitabine for trastuzumab-resistant HER2-positive breast cancer. His research also delves into immune resistance mechanisms, particularly in triple-negative breast cancer, and the role of chromatin remodeling molecules like ARID1A in metastatic heterogeneity. Additionally, he is engaged in clinical and preclinical studies of new therapies, such as the highly selective HER2 inhibitor DZD1516, and the novel anti-PD-L1 monoclonal antibody MSB2311. Prof. Hu’s research aims to improve early diagnosis, treatment strategies, and survival outcomes for breast cancer patients, particularly those with recurrent and metastatic forms of the disease.

Publications:

Prof. Hu has authored 305 papers, including key publications in top-tier SCI journals. His research covers critical areas such as hormone receptor-positive breast cancer, HER2-low breast cancer heterogeneity, and novel cancer therapies. His work, including recent publications in prestigious journals like Cancer Med and BMC Med, highlights his ongoing contributions to advancing oncology.

Conclusion:

Prof. Xichun Hu’s outstanding qualifications, numerous awards, influential professional experience, dedication to teaching, and extensive publication record collectively demonstrate his exceptional impact on the field of oncology. His continuous contributions to cancer research and patient care make him a fitting candidate for the Research for Best Researcher Award.

Publication Tob Noted:

GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases

Journal: Scientific Data

Date: June 10, 2023

DOI: 10.1038/s41597-023-02257-1

Contributors: Ziteng Li, Hena Zhang, Qin Li, Wanjing Feng, Xiya Jia, Runye Zhou, Yi Huang, Yan Li, Zhixiang Hu, Xichun Hu, et al.

Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial

Journal: Acta Pharmaceutica Sinica B

Date: May 2023

DOI: 10.1016/j.apsb.2023.02.001

Contributors: Binghe Xu, Qingyuan Zhang, Xichun Hu, Qing Li, Tao Sun, Wei Li, Quchang Ouyang, Jingfen Wang, Zhongsheng Tong, Min Yan, et al.

Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases

Journal: Cancer Medicine

Date: January 2023

DOI: 10.1002/cam4.4973

Contributors: Peng Qi, Yifeng Sun, Xin Liu, Sheng Wu, Yixin Wo, Qinghua Xu, Qifeng Wang, Xichun Hu, Xiaoyan Zhou

Phase I Study of A166, a Novel Antibody-Drug Conjugate in Advanced HER2-expressing Solid Tumors

Type: Preprint

Date: November 1, 2022

DOI: 10.21203/rs.3.rs-2179560/v1

Contributors: Xichun Hu, Jian Zhang, Rujiao Liu, Shuiping Gao, Wenhua Li, Yang Chen, Yanchun Meng, Chang Liu, Wenyue Jin, Shuli Yi, et al.

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

Journal: Journal of Clinical Oncology

Date: March 1, 2021

DOI: 10.1200/JCO.20.02712

Contributors: Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, Qi Li, Nong Xu, Xi-Chun Hu, Wangjun Liao, Yi Jiang, Xiao-Yan Lin, Qing-yuan Zhang, et al.

Kelly Yoo | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Kelly Yoo | Medicine | Best Researcher Award

Clinician Scientist at Stanford University, United States

Summary:

Dr. Kelly Yoo, M.D., Ph.D., is a distinguished neurosurgeon and postdoctoral fellow at Stanford University School of Medicine. She began her education at Yeomdong Elementary School in Seoul, South Korea, where she was recognized as a top student in the gifted class. She continued her studies at the International School of Hamburg in Germany, earning an International Baccalaureate (IB) Diploma with distinction. Dr. Yoo pursued her medical education at Heidelberg University School of Medicine, excelling academically and completing her MD/PhD program with top honors. Her doctoral research focused on enhancing CAR T cell therapy for B cell malignancies, earning her a Magna cum laude distinction. Dr. Yoo’s residency training includes positions at Heidelberg University Hospital, Klinikum of Ludwig-Maximilians-University of Munich, and University Medical Center Freiburg, consistently ranking among the top of her peers. Since September 2022, she has been advancing her research and clinical expertise as a postdoctoral fellow at Stanford. In addition to her medical career, Dr. Yoo is dedicated to mentoring and teaching, having co-founded MedSchool Mentor to support future medical professionals. Her contributions to education and research have established her as a prominent figure in neurosurgery and oncology.

Profile:

Education:

Dr. Kelly Yoo began her academic journey at Yeomdong Elementary School in Seoul, South Korea, where she was a school representative and part of the gifted class with an IQ of 145, earning a Certificate of Distinction for being in the top 0.1%. She continued her education at Yeomgyeong Middle School, also in Seoul, before moving to Germany to attend the International School of Hamburg. There, she completed the International Baccalaureate (IB) Diploma, received a Certificate of Distinction for being in the top 0.1%, and participated in grade acceleration and gifted education. Dr. Yoo pursued her medical studies at Heidelberg University School of Medicine from October 2012 to October 2019. She excelled in her academic performance, consistently ranking in the top 1% of her class and achieving top 10% marks in her medical state examinations. She completed the MD/PhD Program at Heidelberg University, earning her German Medical License (Approbation) in November 2019. Her doctoral research at the Department of Internal Medicine V / Hematology Oncology at Heidelberg University Hospital focused on tumor-specific reactive oxygen species accelerators to improve Chimeric Antigen Receptor (CAR) T cell therapy in B cell malignancies, for which she received a Magna cum laude distinction. Additionally, Dr. Yoo furthered her education through various programs and internships at Johns Hopkins University, Seoul National University Hospital, and Thoraxklinik at Heidelberg University Hospital, among others.

Professional Experience:

Dr. Kelly Yoo has built an impressive professional career in neurosurgery and oncology. She began her residency in neurosurgery at Kopfklinik, Heidelberg University Hospital (UKHD), where she ranked in the top 1% of her peers. She then completed a residency in radiation oncology at Klinikum of Ludwig-Maximilians-University of Munich, achieving top 10% recognition. Returning to neurosurgery, she pursued further residency training at University Medical Center Freiburg (UKF), where she distinguished herself in the top 0.1%. Since September 2022, Dr. Yoo has been a postdoctoral fellow in the Department of Neurosurgery at Stanford University School of Medicine. In this role, she continues to advance her research and clinical expertise, contributing to cutting-edge developments in neurosurgery. Her dedication to excellence is evident throughout her career, from her clinical practice to her commitment to mentoring and teaching the next generation of medical professionals.

Research Interest:

Dr. Kelly Yoo’s research interests are deeply rooted in advancing the fields of neurosurgery and oncology. Her doctoral research focused on enhancing Chimeric Antigen Receptor (CAR) T cell therapy for B cell malignancies by using tumor-specific reactive oxygen species accelerators, a project that earned her a Magna cum laude distinction. She is particularly interested in the intersection of immunotherapy and neurosurgery, aiming to develop innovative treatments that improve patient outcomes in malignant and non-malignant brain disorders. At Stanford University, Dr. Yoo continues to explore cutting-edge therapies and techniques, with a commitment to translating her research findings into clinical applications that can benefit patients globally. Her work is characterized by a dedication to precision medicine and the use of advanced neuroimaging and neuromonitoring technologies to enhance the effectiveness and safety of neurosurgical procedures.

Awards and Honors:

Dr. Kelly Yoo has garnered numerous awards and honors throughout her distinguished career. In her early education, she was recognized as part of the gifted class at Yeomdong Elementary School and received a Certificate of Distinction for being in the top 0.1% of her peers. During her high school years at the International School of Hamburg, she earned another Certificate of Distinction for her exceptional performance in the International Baccalaureate (IB) program. Her academic excellence continued at Heidelberg University School of Medicine, where she consistently ranked in the top 1% of her class and achieved top 10% marks in her medical state examinations. Her groundbreaking doctoral research on enhancing CAR T cell therapy for B cell malignancies earned her a Magna cum laude distinction. In her professional career, Dr. Yoo received Certificates of Empowerment for being among the top residents at Kopfklinik, Heidelberg University Hospital, Klinikum of Ludwig-Maximilians-University of Munich, and University Medical Center Freiburg. These accolades reflect her outstanding contributions to neurosurgery and oncology, underscoring her dedication to clinical excellence and innovative research.

Publication:

The Role of CyberKnife Stereotactic Radiosurgery in Recurrent Cranial Medulloblastomas across Pediatric and Adult Populations

  • Authors: K.H. Yoo, N.J. Marianayagam, D.J. Park, … A. Meola, S.D. Chang
  • Journal: Journal of Clinical Medicine
  • Year: 2024
  • Volume: 13(12)
  • Page: 3592
  • Citations: 0

Therapeutic approaches for spinal synovial sarcoma: a comprehensive review of the literature

  • Authors: A. Zamarud, S. Shahnoor, A. Maryyum, … D.J. Park, S.D. Chang
  • Journal: Journal of Neurosurgery: Spine
  • Year: 2024
  • Volume: 40(6)
  • Pages: 782-789
  • Citations: 0

Surgery and stereotactic radiosurgery for spinal leiomyosarcoma: a single-institution retrospective series and systematic review

  • Authors: A. Zamarud, N.J. Marianayagam, V. Sekar, … S.D. Chang, A. Meola
  • Journal: Journal of Neurosurgery: Spine
  • Year: 2024
  • Volume: 40(4)
  • Pages: 485-497
  • Citations: 0

Stereotactic Radiosurgery for Cranial and Spinal Hemangioblastomas: A Single-Institution Retrospective Series

  • Authors: K.H. Yoo, D.J. Park, N.J. Marianayagam, … S.D. Chang, A. Meola
  • Journal: Neurosurgery
  • Year: 2024
  • Volume: 94(3)
  • Pages: 630-642
  • Citations: 1

Evaluating Computer Vision, Large Language, and Genome-Wide Association Models in a Limited Sized Patient Cohort for Pre-Operative Risk Stratification in Adult Spinal Deformity Surgery

  • Authors: E. Schonfeld, A. Pant, A. Shah, … G. Haider, A. Veeravagu
  • Journal: Journal of Clinical Medicine
  • Year: 2024
  • Volume: 13(3)
  • Page: 656
  • Citations: 0

The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience

  • Authors: A. Zamarud, N.J. Marianayagam, D.J. Park, … A. Meola, S.D. Chang
  • Journal: Journal of Neuro-Oncology
  • Year: 2023
  • Volume: 165(2)
  • Pages: 373-379
  • Citations: 2

Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation

  • Authors: A. Zamarud, D.J. Park, T.H. Ung, … S.D. Chang, A. Meola
  • Journal: World Neurosurgery
  • Year: 2023
  • Volume: 179
  • Pages: e366-e373
  • Citations: 1

Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases

  • Authors: K.H. Yoo, D.J. Park, J.H. Choi, … A. Meola, S.D. Chang
  • Journal: Frontiers in Oncology
  • Year: 2023
  • Volume: 13
  • Article: 1223599
  • Citations: 3

Stereotactic radiosurgery for distant brain metastases secondary to esthesioneuroblastoma: a single-institution series

  • Authors: A. Zamarud, U. Yener, K.H. Yoo, … S.D. Chang, A. Meola
  • Journal: Neurosurgical Focus
  • Year: 2023
  • Volume: 55(2)
  • Article: E6
  • Citations: 1

Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience

  • Authors: A. Zamarud, D.J. Park, D.Y.A. Dadey, … S.D. Chang, A. Meola
  • Journal: Neurosurgical Focus
  • Year: 2023
  • Volume: 55(2)
  • Article: E7
  • Citations: 1

 

Dagne Dinagde | Health Science | Excellence in Research

Posted on by ScienceFather

Mr. Dagne Dinagde | Health Science | Excellence in Research

Lecturer at Mattu University, Ethiopia

Summary:

Mr. Dagne Dinagde is a distinguished midwifery professional and academic, currently holding a Bachelor of Science degree in Health Science with a specialization in Midwifery from Mattu University, where he graduated with a remarkable CGPA of 3.95 in 2019. He further advanced his expertise by obtaining a Master of Science degree in Clinical Midwifery from Arba Minch University in 2023, graduating with distinction and a CGPA of 3.58. Mr. Dinagde has an impressive research portfolio with 14 publications in health science, serving as the principal investigator for 11 of them. He has also contributed to academia as a lecturer at Mattu University for two years. His professional achievements have been recognized with certificates and recommendation letters from various esteemed institutions, including the Oromia Regional Bureau, Arba Minch General Hospital, and Mattu University’s Gender and HIV/AIDS Issues department.

Profile:

Education:

Mr. Dagne Dinagde obtained his Bachelor of Science degree in Health Science with a specialization in Midwifery from Mattu University on June 27, 2019, achieving an outstanding CGPA of 3.95. He then pursued a Master of Science degree in Clinical Midwifery at Arba Minch University, which he completed with distinction on May 11, 2023, earning a CGPA of 3.58. His master’s research thesis received a ‘Very Good’ rating, equivalent to an A- grade (84%).

Professional Experience:

Mr. Dagne Dinagde has accumulated valuable professional experience in the field of midwifery. He has served as a lecturer at Mattu University for two years, where he contributed to the academic development of students. His role involved teaching, mentoring, and participating in various academic activities to enhance the quality of education in health sciences.

Research Interest:

Mr. Dagne Dinagde’s research interests are centered around various areas of health science, particularly in midwifery. His focus includes improving clinical practices in midwifery, enhancing maternal and child health outcomes, and exploring innovative approaches in clinical midwifery. He is also dedicated to conducting research that addresses public health challenges and contributes to the advancement of healthcare services. Mr. Dinagde has actively participated in numerous research projects, with a strong emphasis on evidence-based practices and healthcare improvement.

Publication:

 

 

Teshome Regasa | Heath Professional Award | Best Researcher Award

Posted on by ScienceFather

Mr. Teshome Regasa, Heath Professional Award, Best Researcher Award

Teshome Regasa at Dilla University, Ethiopia

Mr. Teshome Regasa is a dedicated healthcare professional with expertise in anesthesia and clinical care. He completed his Bachelor of Science in Anesthesia from Jimma University and went on to pursue a Master of Science in Advanced Clinical Anesthesia at Dilla University. Throughout his career, Mr. Regasa has been actively involved in various healthcare initiatives and pandemic response efforts. He has contributed significantly to the establishment of healthcare facilities, including primary hospitals and pandemic management teams. Mr. Regasa is committed to providing high-quality care to patients and continuously seeks opportunities for professional development. His passion for improving healthcare services and his dedication to his field make him a valuable asset to the healthcare community.

Profile:

Education:

Bachelor of Science in Anesthesia

Institution: Jimma University

Duration: September 2009 – July 2013

Master of Science in Advanced Clinical Anesthesia

Thesis Title: Comparison Of Prophylactic Dexamethasone, Metoclopramide, And Combination Of Dexamethasone And Metoclopramide For Prevention Of Postoperative Nausea And Vomiting After Laparoscopic Surgery

Institution: Dilla University

Duration: April 2017 – May 2019

Professional Experience:

July 2015 – October 2015: Junior Medical Laboratory Technologist at Shegaw Motta Y/Hospital, Motta, Ethiopia.

October 2015 – October 2017: Senior Medical Laboratory Technologist at Janmeda Health Center, Addis Ababa, Ethiopia.

October 2017 – Present: Lecturer at Dilla University, Ethiopia, where he actively contributes to the education and training of future healthcare professionals.

November 2019 – December 2021: Participation in the establishment of Yirgachefe Primary Hospital operation theatre and provision of anesthesia service.

December 2020: Contribution to COVID-19 pandemic management team voluntarily, including working at isolation and treatment centers, ICU, and operation room services in Gedeo Zone, Dilla, Ethiopia.

April 2022: Contribution as a Research reviewer for Dilla University staff.

Research Interest:

Mr. Teshome Regasa’s research interests encompass several areas within the field of anesthesia and clinical care. He is particularly interested in investigating strategies for improving perioperative care and patient outcomes, with a focus on anesthesia management techniques, postoperative nausea and vomiting prevention, and pain management. Additionally, Mr. Regasa is interested in exploring the efficacy and safety of different anesthesia medications and techniques, as well as their impact on patient recovery and satisfaction. Furthermore, he is interested in conducting research on the utilization of technology in anesthesia practice, such as the implementation of enhanced recovery after surgery (ERAS) protocols and the integration of telemedicine in perioperative care delivery. Through his research endeavors, Mr. Regasa aims to contribute to the advancement of anesthesia practice and the enhancement of patient care quality in healthcare settings

Publication Top Noted:

Title: Incidence of Postoperative Sore Throat and Associated Factors Among Pediatric Patients Undergoing Surgery Under General Anesthesia at Hawassa University Comprehensive Specialized Hospital, a Prospective Cohort Study

  • Authors: Hailu, S., Shiferaw, A., Regasa, T., Mossie, A., Besha, A.
  • Journal: International Journal of General Medicine
  • Year: 2023
  • Volume: 16
  • Pages: 589–598

Title: Determinants of postoperative emergence delirium in patient undergoing general anesthesia in Dilla University referral hospital. A case-control study

  • Authors: Regasa, T., Aweke, Z., Neme, D.
  • Journal: Annals of Medicine and Surgery
  • Year: 2022
  • Volume: 84
  • Pages: 104942

Title: Anesthetists knowledge, practices, and associated factors towards infection prevention in Addis Ababa public hospitals, Addis Ababa, Ethiopia

  • Authors: Alemayehu, T., Tesfaye, B., Woldeyohannes, M., Regasa, T., Neme, D.
  • Journal: International Journal of Surgery Open
  • Year: 2022
  • Volume: 49
  • Pages: 100573

Title: A rare case of intestinal obstruction secondary to bolus of Ascaris Lumbricoides infestation: A case report and review of the literatures

  • Authors: Hailu, S., Ayinie, A., Tegegn, E., Regasa, T.
  • Journal: International Journal of Surgery Open
  • Year: 2022
  • Volume: 44
  • Pages: 100504

Title: Effect of anesthesia choice on hemodynamic stability and fetomaternal outcome of the preeclamptic patient undergoing cesarean section

  • Authors: Neme, D., Aweke, Z., Jemal, B., Zemedkun, A., Sintayhu, A.
  • Journal: Annals of Medicine and Surgery
  • Year: 2022
  • Volume: 77
  • Pages: 103654

Title: Blind nasal intubation as an alternative airway management modality for bilateral temporomandibular joint ankylosis in a resource constrained set-up: A clinical case report

  • Authors: Zemedkun, A., Angasa, D., Gobena, N., Regasa, T.
  • Journal: International Journal of Surgery Open
  • Year: 2022
  • Volume: 42
  • Pages: 100467